![PDF) Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response PDF) Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response](https://i1.rgstatic.net/publication/235365939_Significance_of_HE4_estimation_in_comparison_with_CA125_in_diagnosis_of_ovarian_cancer_and_assessment_of_treatment_response/links/54435c6a0cf2a76a3ccb105a/largepreview.png)
PDF) Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
![Table 2 from Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar Table 2 from Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f50dc44db73d02a0fdaecab49c845d96479f6e8f/3-Table2-1.png)
Table 2 from Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
![Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825811009735-fx2.jpg)
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
![Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population](https://www.mdpi.com/cancers/cancers-14-02124/article_deploy/html/images/cancers-14-02124-g001.png)
Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
![HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients | BMC Cancer | Full Text HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-022-09887-5/MediaObjects/12885_2022_9887_Fig1_HTML.png)
HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients | BMC Cancer | Full Text
Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry
![Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy](https://pub.mdpi-res.com/diagnostics/diagnostics-13-00452/article_deploy/html/images/diagnostics-13-00452-g001.png?1675751411)
Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE
![Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download](https://slideplayer.com/slide/6626598/23/images/4/Questions+Is+HE4+a+specific+tumor+marker.jpg)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2487ea26-1e5f-4b40-9ecd-fddbb803589d/ntbl003.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer](https://www.frontiersin.org/files/Articles/364491/fonc-08-00124-HTML/image_m/fonc-08-00124-g001.jpg)
Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
![HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6606092/MediaObjects/41416_2011_Article_BF6606092_Fig1_HTML.jpg)
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer
![Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-01544-4/MediaObjects/41598_2021_1544_Fig1_HTML.png)
Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine | Scientific Reports
![Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2F1746-1596-8-11/MediaObjects/13000_2012_Article_730_Fig1_HTML.jpg)